UK ready for roll-out but Pfizer CEO 'not certain' if vaccine stops transmission
Days after getting back-to-back approvals from the United Kingdom (UK) and Bahrain health regulatory bodies for the emergency use of its coronavirus vaccine, Pfizer Inc CEO Albert Bourla is now "not certain" if the company-made vaccine to prevent the Covid-19 can actually stop the transmission of the infection. The basic.
The doubt whether Pfizer's Covid-19 vaccine candidate, with 95 per cent efficacy against Covid-19 vaccine, does prevent its transmission comes as the UK gets ready to roll-out the first batch of 800,000 doses of the coronavirus vaccine. Britain's business minister Alok Sharma is confident the first batch of 800,000 doses of Pfizer's coronavirus vaccine would be in place to begin roll-out next week.